Single cell demand The company specializes in single cell genomics workflows (DOPlify and PG-Seq) and has a focus on enabling sequencing from minimal DNA inputs, presenting a clear upsell path for advanced library preparation kits, amplification reagents, and supplementary sequencing services.

IVDR enabled kits Recent launch of IVDR compliant kits positions PerkinElmer as a compliant supplier for clinical workflows, offering an opportunity to cross-sell nucleic acid purification solutions and integrated chemagic instruments to labs expanding into regulated clinical testing.

Genomics service provider Recognition as a 10x Genomics Certified Service Provider signals credibility in high-end single-cell analysis; potential cross-selling of expansion services, workflows, and validated protocols to institutions seeking reliable turnkey genomics capabilities.

PoC diagnostics synergy Past and ongoing PoC antigen test initiatives imply capability in rapid diagnostics; sales opportunities exist to bundle genomics capabilities with point-of-care testing instruments or to offer integrated diagnostics workflows for translational research and clinical labs.

SMB to mid-market growth With revenue under $1M and a large parent in a high-volume market, there is an opportunity to target growing academic labs and biotech startups needing scalable single-cell kits, training, and support packages to drive adoption and repeat orders.